With regards to the above, the bulk of the tumor might include a distinct group of cells that utilizes either an SMO-dependent or SMO-independent route of GLI activation, or both—with the SMO-independent one likely being the preferential route supported by the fact that mutations in Hh components upstream of GLI are largely absent in most cancer types [228]. This evidence concerns the gene GLI1 and cancer.